Human leptin induces angiogenesis in vivo

Area of Science:

• Endocrinology
• Angiogenesis Research
• Vascular Biology

Background:

• Leptin is a key peptide hormone produced by adipocytes, regulating body weight.
• Previous in vitro studies suggested leptin's role in stimulating endothelial cell proliferation and capillary-like tube formation.

Purpose of the Study:

• To investigate the in vivo angiogenic effect of leptin using the disc angiogenesis system.
• To compare the angiogenic potency and time course of leptin with vascular endothelial growth factor (VEGF).

Main Methods:

• Leptin-containing discs (25-250 ng/ml) were implanted subcutaneously in Wistar rats.
• Angiogenesis was assessed at 7 and 14 days, comparing with spontaneous and VEGF controls.
• Morphological and immunohistochemical analyses quantified vessel development; specificity was confirmed using an anti-leptin antibody.

Main Results:

• Leptin induced significant, dose-dependent angiogenesis in vivo, peaking at 100 ng/ml.
• The angiogenic effect of leptin was completely blocked by a neutralizing anti-leptin antibody, confirming specificity.
• Leptin's angiogenic response was significantly greater than VEGF's at 7 days but comparable at 14 days.

Conclusions:

• Leptin exhibits a specific, dose- and time-dependent angiogenic effect in vivo within the tested concentration range.
• Leptin's angiogenic activity is comparable to VEGF but manifests earlier.
• These findings highlight leptin's potential role in physiological and pathological angiogenesis.